Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine

References

• World Health Organization. 28 February 2014, Summary of surveillance and investigation findings. http://www.who.int/influenza/human_animal_interface/influenza_h7n9/140225_H7N9RA_for_web_20140306FM.pdf?ua=1
   Google Scholar
• Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004; 10:2196-9; PMID:15663860; http://dx.doi.org/10.3201/eid1012.040961
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Notes from the field: Highly pathogenic avian influenza A (H7N3) virus infection in two poultry workers–Jalisco, Mexico, July 2012. MMWR Morb Mortal Wkly Rep 2012; 61:726-7; PMID:22971746
   PubMedGoogle Scholar
• Belser JA, Bridges CB, Katz JM, Tumpey TM. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis 2009; 15:859-65; PMID:19523282; http://dx.doi.org/10.3201/eid1506.090072
   PubMed Web of Science ®Google Scholar
• Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004; 101:1356-61; PMID:14745020; http://dx.doi.org/10.1073/pnas.0308352100
   PubMed Web of Science ®Google Scholar
• Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368:1888-97; PMID:23577628; http://dx.doi.org/10.1056/NEJMoa1304459
   PubMed Web of Science ®Google Scholar
• Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013; 381:1916-25; PMID:23623390
   PubMed Web of Science ®Google Scholar
• Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, Zhang X, Yen HL, Shi B, Li T, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381:2273-9; PMID:23726392
   PubMed Web of Science ®Google Scholar
• Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 2013; 381:1926-32; PMID:23643111; http://dx.doi.org/10.1016/S0140-6736(13)60938-1
   PubMed Web of Science ®Google Scholar
• Liu Q, Lu L, Sun Z, Chen GW, Wen Y, Jiang S. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect 2013; 15:432-9; PMID:23628410; http://dx.doi.org/10.1016/j.micinf.2013.04.004
   PubMedGoogle Scholar
• Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, et al. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun 2013; 4:2854; PMID:24326875; http://dx.doi.org/10.1038/ncomms3854
   PubMed Web of Science ®Google Scholar
• Wood JM, Schild GC, Newman RW, Seagroatt V. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand 1977; 5:237-47; PMID:408355; http://dx.doi.org/10.1016/S0092-1157(77)80008-5
   PubMedGoogle Scholar
• WHO. Generic protocol for the calibration of seasonal/pandemic influenza antigen working reagents by WHO Essential Regulatory Laboratories. 2012
   Google Scholar
• Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, et al. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. Biologicals 2010; 38:284-9; PMID:20074976; http://dx.doi.org/10.1016/j.biologicals.2009.12.004
   PubMed Web of Science ®Google Scholar
• Harvey R, Wheeler JX, Wallis CL, Robertson JS, Engelhardt OG. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine 2008; 26:6550-4; PMID:18840494; http://dx.doi.org/10.1016/j.vaccine.2008.09.050
   PubMedGoogle Scholar
• Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Vaccine 2010; 28:2442-9; PMID:20074687; http://dx.doi.org/10.1016/j.vaccine.2009.12.079
   PubMed Web of Science ®Google Scholar
• Khurana S, Larkin C, Verma S, Joshi MB, Fontana J, Steven AC, King LR, Manischewitz J, McCormick W, Gupta RK, et al. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. Vaccine 2011; 29:5657-6518.
   PubMed Web of Science ®Google Scholar
• Garcia-Canas V, Lorbetskie B, Bertrand D, Cyr TD, Girard M. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection. Anal Chem 2007; 79:3164-72; PMID:21704111; http://dx.doi.org/10.1016/j.vaccine.2011.06.014
   PubMedGoogle Scholar
• Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE. Vaccine 2012; 30:4762-70; PMID:22643214; http://dx.doi.org/10.1016/j.vaccine.2012.05.036
   PubMed Web of Science ®Google Scholar
• Chun S, Li C, Van Domselaar G, Wang J, Farnsworth A, Cui X, Rode H, Cyr TD, He R, Li X. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine 2008; 26:6068-76; PMID:19007587; http://dx.doi.org/10.1016/j.vaccine.2008.09.015
   PubMed Web of Science ®Google Scholar
• Li C, Jaentschke B, Song Y, Wang J, Cyr TD, Van Domselaar G, He R, Li X. A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide. Nat Protoc 2010; 5:14-9; PMID:20010723; http://dx.doi.org/10.1038/nprot.2009.200
   PubMed Web of Science ®Google Scholar
• Hardy S, Eichelberger M, Griffiths E, Weir JP, Wood D, Alfonso C. Confronting the next pandemic–workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27–29, 2010. Influenza Other Respir Viruses 2011; 5:438-42; PMID:21668676; http://dx.doi.org/10.1111/j.1750-2659.2011.00250.x
   PubMedGoogle Scholar
• Elmgren L, Li X, Wilson C, Ball R, Wang J, Cichutek K, Pfleiderer M, Kato A, Cavaleri M, Southern J, et al. A global regulatory science agenda for vaccines. Vaccine 2013; 31 Suppl 2:B163-75; PMID:23598478
   PubMedGoogle Scholar
• Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010; 363:2416-23; PMID:21158658; http://dx.doi.org/10.1056/NEJMoa1006736
   PubMed Web of Science ®Google Scholar
• La Montagne JR, Noble GR, Quinnan GV, Curlin GT, Blackwelder WC, Smith JI, Ennis FA, Bozeman FM. Summary of clinical trials of inactivated influenza vaccine – 1978. Rev Infect Dis 1983; 5(4):723-36; PMID:6353529; http://dx.doi.org/10.1093/clinids/5.4.723
   PubMedGoogle Scholar
• Cate TR, Couch RB, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines – 1978. Rev Infect Dis 1983; 5(4):737-47; PMID:6622888; http://dx.doi.org/10.1093/clinids/5.4.737
   PubMedGoogle Scholar
• Hashem AM, Gravel C, Farnsworth A, Zou W, Lemieux M, Xu K, Li C, Wang J, Goneau MF, Merziotis M, et al. A novel synthetic receptor-based immunoassay for influenza vaccine quantification. PLoS One 2013; 8(2):e55428; PMID:23424631; http://dx.doi.org/10.1371/journal.pone.0055428
   PubMedGoogle Scholar
• Campbell PJ. International biological standards and reference preparations. I. Preparation and presentation of materials to serve as standards and reference preparations. J Biol Stand 1974; 2:249-58; PMID:4459394; http://dx.doi.org/10.1016/0092-1157(74)90033-X
   PubMedGoogle Scholar
• Xu K, Shao M, Liu S, Cai F, Gao Q, Li C, Wang J. Rapid preparation of antiserum against influenza virus(H7N9) hemagglutinin for single radial immunodiffusion assay. Chin J Microbiol Immunol 2014; 24:146-8
   Google Scholar